Diseases, Conditions, Syndromes

Physicians report expanding use of off-label COVID-19 treatments

Hydroxychloroquine usage is expanding globally to treat novel coronavirus 2019 (COVID-19), although plasma from recovered patients is perceived as more effective than hydroxychloroquine, according to a report released by ...

Diseases, Conditions, Syndromes

Researchers launch vital COVID-19 clinical trials

Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs—hydroxychloroquine (HCQ) and azithromycin—to ...

Medications

Side effects seen with use of chloroquine against COVID-19

(HealthDay)—The use of the antimalarial drug chloroquine to treat COVID-19 patients has been halted at several Swedish hospitals due to reported side effects such as cramps and loss of peripheral vision. Sahlgrenska University ...

Diseases, Conditions, Syndromes

ATS publishes new guidance on COVID-19 management

An American Thoracic Society-led international task force has released a guidance document to help clinicians manage COVID-19 patients in the face of a worldwide pandemic and minimal empirical evidence to guide treatment. ...

Diseases, Conditions, Syndromes

Senegal says hydroxychloroquine virus treatment is promising

Senegal is set to continue administering hydroxychloroquine to coronavirus patients, a senior health official said Thursday, after encouraging results for those treated with the venerable anti-malarial drug.

Diseases, Conditions, Syndromes

Malaria drugs' promise for coronavirus spurs hope, shortages

Excitement about treating the new coronavirus with malaria drugs is raising hopes, including with President Donald Trump. But the evidence that they may help is thin, and a run on the drugs is complicating access for people ...

page 8 from 10